Analyzing Risks in COVID-19 Vaccination in Italy
Author Information
Author(s): Balestracci Beatrice, Candido Giuseppe, Federici Lorenzo, Parretti Chiara, Tartaglia Riccardo, Lachman Peter, Bianco Alessandra, La Regina Micaela, Gómez-Cantarino Sagrario, Geisler Anja Edith
Primary Institution: Department of Engineering Sciences, Guglielmo Marconi University
Hypothesis
What are the patient safety threats related to the anti-COVID-19 large-scale vaccination process?
Conclusion
The study emphasizes the importance of ensuring patient safety and effective clinical risk management in mass vaccination campaigns.
Supporting Evidence
- 157,792 doses of the COVID-19 vaccine were administered during the study.
- The FMECA analysis identified critical steps in the vaccination process that could lead to serious harm.
- High-risk phases included managing severe allergic reactions and ensuring vaccination teams were well-trained.
- Twenty interventions were implemented to improve the vaccination process and mitigate risks.
Takeaway
This study looked at how to keep people safe during COVID-19 vaccinations by finding and fixing problems before they happen.
Methodology
The study used the Failure Mode, Effects, and Criticality Analysis (FMECA) technique to identify risks in the vaccination process.
Potential Biases
The results are influenced by the experience of the professionals conducting the analysis.
Limitations
The study's findings may vary based on the professionals involved, and it did not incorporate patient input during the analysis.
Participant Demographics
The study involved a multidisciplinary team from various healthcare backgrounds.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website